Nuveen Asset Management, LLC Fibrogen Inc Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.49 - $20.59 $2.02 Million - $16.7 Million	-813,201 Reduced 90.73%	83,092 $224,000
Q1 2023 May 15, 2023	BUY	$15.95 - $25.18 $5.25 Million - $8.28 Million	328,958 Added 57.98%	896,293 $16.7 Million
Q4 2022 Feb 14, 2023	SELL	$13.27 - $17.73 $343,653 - $459,153	-25,897 Reduced 4.37%	567,335 $9.09 Million
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $3.74 Million - $4.79 Million	328,407 Added 124.01%	593,232 $7.72 Million
Q2 2022 Aug 15, 2022	BUY	$7.94 - $12.96 $17,666 - $28,836	2,225 Added 0.85%	264,825 $2.8 Million
Q1 2022 May 16, 2022	SELL	$12.02 - $16.79 $977,574 - $1.37 Million	-81,329 Reduced 23.65%	262,600 $3.39 Million
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $47,743 - $73,995	-4,808 Reduced 1.38%	343,929 $4.85 Million
Q3 2021 Nov 12, 2021	SELL	$10.18 - $26.64 $697,828 - $1.83 Million	-68,549 Reduced 16.43%	348,737 $3.56 Million
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $675,818 - $1.3 Million	36,393 Added 9.55%	417,286 $11.1 Million
Q1 2021 May 17, 2021	SELL	$31.0 - $55.72 $1.14 Million - $2.06 Million	-36,883 Reduced 8.83%	380,893 $13.2 Million
Q4 2020 May 17, 2021	SELL	$37.09 - $48.97 $931,960 - $1.23 Million	-25,127 Reduced 5.67%	417,776 $15.5 Million
Q4 2020 Feb 16, 2021	SELL	$37.09 - $48.97 $706,230 - $932,437	-19,041 Reduced 4.12%	442,903 $16.4 Million
Q3 2020 Nov 16, 2020	BUY	$40.47 - $45.5 $9,267 - $10,419	229 Added 0.05%	461,944 $19 Million
Q2 2020 Aug 14, 2020	SELL	$32.57 - $42.83 $1.79 Million - $2.36 Million	-55,102 Reduced 10.66%	461,715 $18.7 Million
Q1 2020 May 14, 2020	SELL	$23.3 - $45.96 $5.43 Million - $10.7 Million	-232,840 Reduced 31.06%	516,817 $18 Million
Q4 2019 Feb 14, 2020	BUY	$34.58 - $48.06 $8.22 Million - $11.4 Million	237,655 Added 46.42%	749,657 $32.2 Million
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $3.46 Million - $4.54 Million	93,690 Added 22.4%	512,002 $18.9 Million
Q2 2019 Aug 15, 2019	BUY	$35.13 - $55.53 $14.2 Million - $22.5 Million	405,512 Added 3168.06%	418,312 $18.9 Million
Q1 2019 May 14, 2019	BUY	$42.83 - $59.91 $548,224 - $766,848	12,800 New	12,800 $696,000
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $865,488 - $1.37 Million	-22,794 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$56.3 - $67.25 $73,190 - $87,425	-1,300 Reduced 5.4%	22,794 $1.39 Million
Q2 2018 Aug 14, 2018	BUY	$44.9 - $64.95 $160,831 - $232,650	3,582 Added 17.46%	24,094 $1.51 Million
Q1 2018 May 14, 2018	SELL	$45.35 - $61.65 $1,859 - $2,527	-41 Reduced 0.2%	20,512 $948,000
Q4 2017 Feb 14, 2018	SELL	$41.95 - $60.1 $2,810 - $4,026	-67 Reduced 0.32%	20,553 $0
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $688,708 - $1.11 Million	20,620	20,620 $1.11 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account